Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Class A Common Stock, $0.01 par value per share
-
Shares outstanding
-
42M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
22.8M
-
Shares change
-
-1.69M
-
Total reported value, excl. options
-
$29.9M
-
Value change
-
-$1.71M
-
Number of buys
-
6
-
Number of sells
-
-22
-
Price
-
$1.31
Significant Holders of RAPID MICRO BIOSYSTEMS, INC. - Class A Common Stock, $0.01 par value per share (RPID) as of Q1 2023
40 filings reported holding RPID - RAPID MICRO BIOSYSTEMS, INC. - Class A Common Stock, $0.01 par value per share as of Q1 2023.
RAPID MICRO BIOSYSTEMS, INC. - Class A Common Stock, $0.01 par value per share (RPID) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.8M shares
of 42M outstanding shares and own 54.26% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (8.43M shares), KENNEDY LEWIS MANAGEMENT LP (4.94M shares), JPMORGAN CHASE & CO (1.46M shares), ABG-WTT Global Life Science Capital Partners GP Ltd (1.04M shares), BlackRock Inc. (1.03M shares), GOLDMAN SACHS GROUP INC (944K shares), GLENVIEW CAPITAL MANAGEMENT, LLC (818K shares), PRICE T ROWE ASSOCIATES INC /MD/ (760K shares), VANGUARD GROUP INC (730K shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (700K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.